Medical Device Company
Appears in 1 story
Competitor with FDA-approved PearlMatrix P-15 bone graft
For 24 years, Medtronic's INFUSE bone graft has followed a winding path through FDA approval, off-label controversy, lawsuits, and now expansion. The Food and Drug Administration (FDA) just granted INFUSE approval for transforaminal lumbar interbody fusion (TLIF) procedures—making it the only growth factor bone graft approved for two-level spinal constructs and the only one cleared for anterior, oblique, and transforaminal approaches.
Updated Feb 17
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
